Use Actual Weight to Dose LMWH in Obese Patients

July 2016

We're getting questions about how to dose low-molecular-weight heparin (LMWH) for venous thromboembolism in obesity and renal impairment.

Dosing a LMWH, such as enoxaparin (Lovenox, etc), can be tricky in these cases. Usual doses may not be enough for obese patients...or they may accumulate and be too high in patients with renal impairment.

Obesity. For acute venous thromboembolism (VTE) treatment, dose LMWH based on ACTUAL body weight...even in patients over 150 kg.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote